A phase I study of daily carboplatin and simultaneous accelerated, hyperfractionated chest irradiation in patients with regionally inoperable non-small cell lung cancer

Nonparametric Estimation from Incomplete Observations

1992 • 45,923 citations

Nonparametric Estimation from Incomplete Observations

1958 • 37,219 citations

Chemotherapy in non-small cell lung cancer: a meta-analysis using updated data on individual patients from 52 randomised clinical trials

1995 • 2,804 citations

Chemotherapy in non-small cell lung cancer: A meta-analysis using updated data on individual patients from 52 randomised clinical trials

1996 • 2,541 citations

Cancer statistics, 1997

1997 • 2,045 citations

Effects of Concomitant Cisplatin and Radiotherapy on Inoperable Non-Small-Cell Lung Cancer

1992 • 1,287 citations

A Randomized Trial of Induction Chemotherapy plus High-Dose Radiation versus Radiation Alone in Stage III Non-Small-Cell Lung Cancer

1990 • 1,163 citations

Improved Survival in Stage III Non-Small-Cell Lung Cancer: Seven-Year Follow-up of Cancer and Leukemia Group B (CALGB) 8433 Trial

1996 • 927 citations

Radiation Therapy Oncology Group (RTOG) 88-08 and Eastern Cooperative Oncology Group (ECOG) 4588: Preliminary Results of a Phase III Trial in Regionally Advanced, Unresectable Non-Small-Cell Lung Cancer

1995 • 721 citations

Southwest Oncology Group standard response criteria, endpoint definitions and toxicity criteria

1992 • 619 citations

Long-term observations of the patterns of failure in patients with unresectable non-oat cell carcinoma of the lung treated with definitive radiotherapy report by the radiation therapy oncology group

1987 • 607 citations

A randomized phase I/II trial of hyperfractionated radiation therapy with total doses of 60.0 Gy to 79.2 Gy: possible survival benefit with greater than or equal to 69.6 Gy in favorable patients with Radiation Therapy Oncology Group stage III non-small-cell lung carcinoma: report of Radiation Therapy Oncology Group 83-11.

1990 • 474 citations

Accelerated fractionation vs hyperfractionation: Rationales for several treatments per day

1983 • 418 citations

Hyperfractionated radiation therapy with or without concurrent low-dose daily carboplatin/etoposide for stage III non-small-cell lung cancer: a randomized study.

1996 • 367 citations

Combination chemotherapy versus single agents followed by combination chemotherapy in stage IV non-small-cell lung cancer: a study of the Eastern Cooperative Oncology Group.

1989 • 325 citations

Randomized trial of hyperfractionated radiation therapy with or without concurrent chemotherapy for stage III non-small-cell lung cancer.

1995 • 296 citations

The Survival of Patients with Inoperable Lung Cancer: A Large-Scale Randomized Study of Radiation Therapy Versus Placebo

1968 • 293 citations

Chemotherapy plus Radiotherapy Compared with Radiotherapy Alone in the Treatment of Locally Advanced, Unresectable, Non-Small-Cell Lung Cancer

1996 • 271 citations

Randomized trials of radiotherapy alone versus combined chemotherapy and radiotherapy in stages IIIa and IIIb nonsmall cell lung cancer: A meta‐analysis

1996 • 248 citations

Randomized trials of radiotherapy alone versus combined chemotherapy and radiotherapy in stages IIIa and IIIb nonsmall cell lung cancer. A meta-analysis

1995 • 241 citations

Combination chemotherapy with cisplatin and etoposide in bronchogenic squamous cell carcinoma and adenocarcinoma. A study by the EORTC lung cancer working party (Belgium)

1982 • 120 citations

Radiotherapy in the management of locally advanced lung cancer of all cell types: Final report of randomized trial

1981 • 117 citations

Brief overview of combination chemotherapy in non-small-cell lung cancer.

1986 • 77 citations

Review of therapeutic trials of carboplatin in lung cancer.

1989 • 75 citations

Enhancement of radiation-induced cell kill by platinum complexes (carboplatin and iproplatin) in V79 cells

1986 • 65 citations

A randomized study of split-course radiotherapy of lung cancer: Long term results

1980 • 64 citations

Comparison of split-course radiation therapy and continuous radiation therapy for unresectable bronchogenic carcinoma: 5 year results

1976 • 61 citations

A phase III study of accelerated radiotherapy with and without carboplatin in nonsmall cell lung cancer: An interim toxicity analysis of the first 100 patients

1995 • 58 citations

109 RTOG 8808 ECOG 4588, preliminary analysis of a phase III trial in regionally advanced unresectable now small cell lung cancer with minimum three year follow-up

1995 • 46 citations

Controversies in the Nonsurgical Treatment of Stage III Non-small Cell Lung Cancer

1992 • 46 citations

Daily low-dose cisplatin plus concurrent high-dose thoracic irradiation in locally advanced unresectable non-small-cell lung cancer: results of a phase II Southwest Oncology Group study.

1994 • 41 citations

Hyperfractionated radiation therapy with and without concurrent chemotherapy for advanced non–small cell lung cancer

1993 • 26 citations

Radiobiological intercomparisons in vivo and in vitro

1977 • 24 citations

Combination chemotherapy followed by radiation therapy in patients with regional stage III unresectable non-small cell lung cancer

1986 • 24 citations

Concurrent daily carboplatin and accelerated hyperfractionated thoracic radiotherapy in locally advanced nonsmall cell lung cancer

1997 • 18 citations

Altered Fractionation for Non-Small Cell Carcinoma of the Lung

1989 • 5 citations

Phase II study of concurrent cisplatin(CDDP)-vindesine(VDS) chemotherapy(CT) plus twice-daily thoracic radiotherapy (TRT) for locally advanced non-small cell lungcancer (NSCLC)

1994 • 3 citations

Deleted Work

1955 • 0 citations